-
Share
583 Posts.
279
29/03/12
22:15
Share
well today was exactly to plan lots of new blood taking positions some short ...and hopefully most going long...
we should see more of the same
Congrats to all at biota
Really exited about our short term prospects
vapendavir licence to big pharma with big up front $$, big mile$tone payments and b ig royalties,
nasdaq gee would be sweet if surprize us earlier than mid year on how this will be acheived...
qtrly sales figures on relenza and inavir...
and we must be due for some news real soon on pandemic stockpile replenishment globally on relenza afterall it was due to begin towards end of 2011...
Progress Barda/ lani update must be around the corner
Hold on tight. make the shorters wish they had never heard of biota
-